Liya Yin

Aldo-keto reductase 1B7 is a target gene of FXR and regulates lipid and glucose homeostasis.

Induction of vascular progenitor cells from endothelial cells stimulates coronary collateral growth.

Resolution of mitochondrial oxidative stress rescues coronary collateral growth in Zucker obese fatty rats.

Coronary collateral growth--back to the future.

Mitochondrial oxidative stress corrupts coronary collateral growth by activating adenosine monophosphate activated kinase-α signaling.

The role of mitochondrial bioenergetics and reactive oxygen species in coronary collateral growth.

Hepatic carboxylesterase 1 is essential for both normal and farnesoid X receptor-controlled lipid homeostasis.

Hepatic carboxylesterase 1 is induced by glucose and regulates postprandial glucose levels.

Dewetting based fabrication of fibrous micro-scaffolds as potential injectable cell carriers.

Novel thiazolidinedione mitoNEET ligand-1 acutely improves cardiac stem cell survival under oxidative stress.

A metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism.

Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation.

Carboxylesterase 2 prevents liver steatosis by modulating lipolysis, endoplasmic reticulum stress, and lipogenesis and is regulated by hepatocyte nuclear factor 4 alpha in mice.

Impaired coronary metabolic dilation in the metabolic syndrome is linked to mitochondrial dysfunction and mitochondrial DNA damage.

Carboxylesterase 1 Is Regulated by Hepatocyte Nuclear Factor 4α and Protects Against Alcohol- and MCD diet-induced Liver Injury.

Farnesoid X receptor activation increases reverse cholesterol transport by modulating bile acid composition and cholesterol absorption in mice.

The versatility and paradox of GDF 11.

Vascular precursor cells in tissue injury repair.

Kv1.3 channels facilitate the connection between metabolism and blood flow in the heart.

Alignment of inducible vascular progenitor cells on a micro-bundle scaffold improves cardiac repair following myocardial infarction.

Global inactivation of carboxylesterase 1 (Ces1/Ces1g) protects against atherosclerosis in Ldlr mice.

Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR.

Epigenetic regulation in diabetes-associated oxidative stress and myocardial dysfunction.

Cardioprotection during ischemia by coronary collateral growth.

Knowns and unknowns of coronary artery development and anomalies.

Lipocalin-2 Protects Against Diet-Induced Nonalcoholic Fatty Liver Disease by Targeting Hepatocytes.

Hepatic Forkhead Box Protein A3 Regulates ApoA-I (Apolipoprotein A-I) Expression, Cholesterol Efflux, and Atherogenesis.

Exosomes derived from induced vascular progenitor cells promote angiogenesis in vitro and in an in vivo rat hindlimb ischemia model.

Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis.

Step by Step: Advancing the Understanding of Local Vascular Control.

Hepatocyte-Specific Expression of Human Carboxylesterase 1 Attenuates Diet-Induced Steatohepatitis and Hyperlipidemia in Mice.

Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice).

Hepatocyte-specific expression of human carboxylesterase 2 attenuates nonalcoholic steatohepatitis in mice.

Hepatocyte ATF3 protects against atherosclerosis by regulating HDL and bile acid metabolism.

Endothelial TRPV4 channels prevent tumor growth and metastasis via modulation of tumor angiogenesis and vascular integrity.

Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease.

Hepatocytic Activating Transcription Factor 3 Protects Against Steatohepatitis via Hepatocyte Nuclear Factor 4α.

The role of MSC derived exosomes on cardiac microvascular dysfunction.

Mechanism of the switch from NO to HO in endothelium-dependent vasodilation in diabetes.

Mitochondrial DNA integrity and function are critical for endothelium-dependent vasodilation in rats with metabolic syndrome.

The essential role for endothelial cell sprouting in coronary collateral growth.

Role of endothelial CXCR4 in the development of aortic valve stenosis.

The Roles of Bone Marrow-Derived Stem Cells in Coronary Collateral Growth Induced by Repetitive Ischemia.

Takotsubo syndrome is a coronary microvascular disease: experimental evidence.

Hepatocyte Sirtuin 6 Protects against Atherosclerosis and Steatohepatitis by Regulating Lipid Homeostasis.

Is miR-21 A Therapeutic Target in Cardiovascular Disease?

Hepatic FOXA3 overexpression prevents Western diet-induced obesity and MASH through TGR5.

Krüppel-like factor 10 protects against metabolic dysfunction-associated steatohepatitis by regulating HNF4α-mediated metabolic pathways.

The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review.

Bone marrow cells contribute to seven different endothelial cell populations in the heart.

Does coronary microvascular dysfunction play a role in heart failure with reduced ejection fraction?